Resveratrol has been proposed as an anti-obesity agent that increases fatty acid oxidation through upregulation of AMPK and PGC-1α [32,33] and downregulation of peroxisome proliferator-activated receptor gamma and CCAAT-enhancer-binding protein [34]. The gene discussed is PPARGC1A; the disease is obesity due to melanocortin 4 receptor deficiency.